Pembrolizumab: Inflammatory arthritis.

A male patient with Hodgkin lymphoma developed inflammatory arthritis while undergoing treatment with pembrolizumab. Initially, he was suspected to have septic arthritis and received antibiotics, but further investigation revealed inflammation and negative cultures. The patient was subsequently diagnosed with inflammatory arthritis and started on steroid treatment. The outcome of the treatment was not specified. [Extracted from the article]